Edaravone Dexborneol ameliorates the cognitive deficits of APP/PS1 mice by inhibiting TLR4/MAPK signaling pathway via upregulating TREM2
Article in Neuropharmacology (May 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Neuropharmacology (May 2024)
Article in Neuroscience (November 2023)
Article in iScience (August 2023)